Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 188.41

-2.4%

Dec 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (4293)	7/25/1997 8:28:00 PM
From: Henry Niman	of 32384

Andy, The arthritis teaser was in error. "Arthritis" should be replaced with "Athrosclerosis". I was recall an AOL post which I had seen earlier today. When I went back this evening, I saw that the poster had mentioned non-diabetic applications such as athroscleosis (which was mis-spelled and I had earlier read it as arthritis) (which was discussed at a recent Helsinki meeting). For athrosclerosis applications, LGND shareholders need go no further than LGND's 1995 Annual report which briefly describes LGND's athrosclerosis alliance with GLX (and targeting of small hormone analogues that interact with PPARs). Of course LGND has its own TZD and PPAR programs (in addition to the GLX alliance) and TZDs (and probably Rexinoids) will have additional applications for that indication (and probably others). Henry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next